Compare GHRP-2, GHRP-6, and sermorelin acetate: how each growth hormone secretagogue works, typical research doses, side effects, and US legal status.
GHRP-2, GHRP-6, and sermorelin acetate are three growth hormone secretagogues that get discussed together because they all push the pituitary to release more growth hormone, but they do it through different receptors. GHRP-2 and GHRP-6 are ghrelin-receptor agonists, while sermorelin is a growth hormone-releasing hormone (GHRH) analog that copies the body's own signal. None of the three is FDA-approved for human use in the United States today, and each carries real safety and legal caveats.
What Are GHRP-2, GHRP-6, and Sermorelin Acetate?
All three belong to the growth hormone secretagogue family, a group of peptides that stimulate the pituitary. They differ in receptor target, half-life, and which other hormones they influence along the way.
GHRP-2 (Pralmorelin)
GHRP-2 is a synthetic six-amino-acid peptide that activates the ghrelin receptor, also called GHS-R1a. It triggers a rapid, pulse-like GH release and, in research models, modest increases in cortisol, prolactin, and aldosterone. Compared with GHRP-6, GHRP-2 is usually described as the stronger GH releaser with a milder effect on hunger.
GHRP-6 (Examorelin)
GHRP-6 hits the same ghrelin receptor as GHRP-2. Its defining trait in the literature is a pronounced increase in appetite, which is why it appears in appetite and wasting-condition research more often than in body composition work. In most head-to-head comparisons, GHRP-6 produces a smaller GH pulse than GHRP-2.
Sermorelin Acetate
If you are wondering what is sermorelin acetate, the short answer is that it is a synthetic 29-amino-acid copy of growth hormone-releasing hormone, the peptide the hypothalamus uses to tell the pituitary to release GH. Because it acts on the GHRH receptor, sermorelin creates a gentler, more physiological pulse and has little effect on appetite, cortisol, or prolactin.
Every sermorelin acetate peptide arrives as a lyophilized powder that must be reconstituted before use. Sermorelin's half-life is short, roughly 10 to 20 minutes, so it clears the body quickly rather than staying active for hours.
How GHRP-2, GHRP-6, and Sermorelin Differ
| Feature | GHRP-2 | GHRP-6 | Sermorelin Acetate |
|---|---|---|---|
| Receptor target | Ghrelin receptor (GHS-R1a) | Ghrelin receptor (GHS-R1a) | GHRH receptor |
| GH release pattern | Strong, rapid pulse | Moderate, rapid pulse | Gentle, physiological pulse |
| Appetite effect | Mild to moderate increase | Strong increase | Minimal |
| Cortisol and prolactin | Modest increase | Modest increase | Minimal change |
| Approximate half-life | 20-30 minutes | 15-60 minutes | 10-20 minutes |
| FDA status for human use | Not approved | Not approved | Former diagnostic approval; product discontinued |
| Typical supply | Research vial | Research vial | Compounded or research vial |
GHRP-2 and GHRP-6 are not FDA-approved for human use in the United States, and they are legally sold only as laboratory research chemicals. Sermorelin previously held FDA approval as a diagnostic drug under the brand name Geref, but that product was discontinued, and sermorelin is now most often supplied by compounding pharmacies.
Research Dosing at a Glance
The numbers below come from published research and widely circulated community protocols. They are not FDA guidance, and they are not a substitute for advice from a clinician.
| Peptide | Commonly cited research dose | Typical frequency | Notes |
|---|---|---|---|
| GHRP-2 | 100-300 mcg | 2-3 times daily, fasted | Largest GH pulse of the three |
| GHRP-6 | 100-300 mcg | 2-3 times daily, fasted | Strongest appetite stimulation |
| Sermorelin acetate | 100-300 mcg (often 200-300 mcg) | Once daily before bed | Mimics the overnight GH pulse |
Timing matters as much as dose. Growth hormone is naturally released in pulses, with the largest occurring after sleep begins, so bedtime dosing is common. Whether someone is researching how to inject sermorelin acetate or reviewing a GHRP protocol, the standard route in research is subcutaneous injection into the abdomen or thigh with a small insulin syringe.
Stacking and Related Peptides
Because the GHRH and ghrelin pathways are complementary, many protocols pair one peptide from each class. The combination of sermorelin and ghrp-2 is the classic example, and published studies show that a GHRH analog plus a ghrelin-receptor agonist produces a substantially larger GH pulse than either compound alone.
Newer analogs come up in the same conversations. In any cjc-1295 vs sermorelin comparison, the decisive difference is duration: CJC-1295 with DAC stays active for days, while sermorelin clears the body within about half an hour. That shorter window is one reason some researchers prefer sermorelin when the goal is to mimic natural overnight release instead of producing a sustained elevation.
A separate comparison is sermorelin vs aod 9604. AOD 9604 is a fragment of human growth hormone studied for fat metabolism, and it does not trigger GH release at all, so it is not an alternative to any of the three peptides covered here.
Side Effects and Safety
None of these peptides is risk-free, and none behaves like a simple supplement. Reported effects overlap but differ in intensity:
- GHRP-2 and GHRP-6: injection-site irritation, flushing, headache, dizziness, water retention, and measurable rises in cortisol, prolactin, and aldosterone. GHRP-6 can cause intense hunger within minutes of a dose.
- Sermorelin acetate: generally milder systemic effects, though injection-site reactions, flushing, and headache are documented. Because it raises growth hormone, it also raises IGF-1 with continued use.
- All three: elevated GH and IGF-1 are a concern for anyone with active cancer or a history of malignancy, and these peptides should not be used during pregnancy or breastfeeding.
Anyone considering a growth hormone secretagogue should review it with a healthcare professional, especially if they take diabetes medication, thyroid medication, or steroids. Self-experimentation with unregulated peptides is a common source of avoidable harm.
Legal Status: GHRP-2, GHRP-6, and Sermorelin Acetate for Sale in the US
Searches for ghrp-2 ghrp-6 sermorelin acetate for sale mostly return three types of sellers: research chemical suppliers, overseas pharmacies, and US telehealth clinics that prescribe compounded sermorelin. Only the last of those operates inside a clear legal framework, and even that pathway has been reviewed repeatedly by regulators.
Purity is the practical problem with research-grade vials. Independent testing has repeatedly found that peptides sold online are underdosed, mislabeled, or contaminated, and a certificate of analysis from the seller is not the same as third-party verification. For a compound that will be injected, that uncertainty is a meaningful risk.
The Bottom Line
- GHRP-2 and GHRP-6 are ghrelin-receptor agonists, while sermorelin acetate is a GHRH analog, so they raise growth hormone through different pathways.
- GHRP-6 stimulates appetite the most, GHRP-2 produces the strongest GH pulse, and sermorelin produces the gentlest and most physiological one.
- None of the three is FDA-approved for human use in the United States today, and GHRP-2 and GHRP-6 are sold only as research chemicals.
- Combining a GHRH analog with a ghrelin-receptor agonist increases the GH response, but it also increases the side-effect profile.
- Anyone using or considering these peptides should do so with medical supervision rather than relying on an online vendor alone.
Frequently Asked Questions
Is GHRP-2 or GHRP-6 legal to buy in the United States?
No. Neither GHRP-2 nor GHRP-6 is FDA-approved for human use, and both are sold legally only as laboratory research chemicals labeled for non-human use. Buying or importing them for personal human use falls outside that research exemption. Sermorelin is different because it has a prescription history and is sometimes available in compounded form with a physician's order.
What is the difference between sermorelin and GHRP-6?
Sermorelin is a GHRH analog that acts on the GHRH receptor and produces a gentler, more physiological GH pulse with little effect on appetite. GHRP-6 acts on the ghrelin receptor and causes a sharper GH release along with a strong increase in hunger and modest rises in cortisol and prolactin. Many research protocols combine a GHRH peptide with a ghrelin-receptor peptide to get a larger combined pulse.
Does sermorelin acetate help with weight loss?
The evidence is limited and mixed. Growth hormone does increase fat breakdown, and some older studies of GHRH analogs showed modest changes in body composition, but sermorelin is not approved or proven as a weight-loss drug. Claims that it causes significant fat loss should be treated cautiously until better controlled trials are available.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.